Cannabis Health Symposium: Frankfurt

Programme

The programme is being finalised — here are the themes we’ll explore across the day.

• Presentation and audience Q&A

  EKOCAN public health findings

  The EKOCAN study has generated some of the first large-scale public health data examining the impact of cannabis reform in Germany. This session will present the latest findings before opening the discussion around what these results mean for patient care, prescribing behaviour and public health policy.

• Panel debate

  Telemedicine: revolution or risk?

  The rapid growth of telemedicine providers following the introduction of CanG has divided the medical cannabis community. Has online access transformed patient care, or has it blurred the line between genuine medical treatment and adult-use access?

• Presentation

  The route to reimbursement

  Although Germany has Europe's largest medical cannabis market, the majority of prescriptions remain privately funded. This session will explore why reimbursement through statutory health insurance remains challenging, what clinicians and other stakeholders can do to improve approval rates, and how evidence, health economics and policy may shape future reimbursement decisions.

• Presentation

  The expanding role and responsibilities of the pharmacist

  As medical cannabis prescribing increases, pharmacists are playing an increasingly important role in ensuring product quality, patient safety and regulatory compliance. This session will explore pharmacy responsibilities including dispensing, compounding, quality assurance, product selection and patient counselling, while addressing the need for greater professional education.

• Presentation

  Driving, employment and patient rights

  Despite legal reform, uncertainty remains regarding driving laws, workplace policies and patient protections. This practical session will provide an overview of the most recent driving regulations, workplace and employment rights and other developments both patients and prescribers need to know.

• Panel or presentation

  Cannabinoids vs opioids: a new class of treatment for chronic pain?

  Chronic pain remains one of the largest unmet needs in healthcare, affecting more than one billion people worldwide. Despite its major medical, social and economic burden, innovation in treatment has substantially lagged behind other major disease areas. After more than a decade in development, the first cannabinoid-based medicine for the treatment of chronic lower back pain received market authorisation in Germany and Austria earlier this year. Does this represent a new frontier in the treatment of chronic pain?

• Presentation

  Safe prescribing in mental health

  Mental health remains one of the most discussed and debated areas of medical cannabis practice. This session will examine the current evidence for cannabis-based medicines in psychiatric conditions, while addressing concerns around safety, dependency, psychosis risk and patient selection — with prescribing considerations, risk mitigation strategies and the role of cannabis-based medicines within wider mental health treatment pathways.

• Panel discussion

  Addressing unmet needs in women's health

  Women are increasingly seeking cannabis-based medicines to manage a range of conditions that are often poorly served by conventional treatment options. This multidisciplinary discussion will explore the use of medical cannabis across conditions such as menopause, endometriosis, PMDD, chronic pelvic pain and related disorders — examining the current evidence, clinical experience and future research priorities, and how healthcare providers can better support women seeking alternative treatment approaches.

• Presentation and audience Q&A

  The ECS: educating the next generation

  Despite growing clinical use of cannabinoid medicines, formal education on the endocannabinoid system remains limited. This session will explore how training on the ECS is developing across universities and professional education for medical professionals.

Speakers

Call for speakers

Partner with us